CUE BIOPHARMA Trademark

Trademark Overview

On Tuesday, October 13, 2020, a trademark application was filed for CUE BIOPHARMA with the United States Patent and Trademark Office. The USPTO has given the CUE BIOPHARMA trademark a serial number of 90252478. The federal status of this trademark filing is REGISTERED as of Tuesday, October 24, 2023. This trademark is owned by CUE BIOPHARMA, INC.. The CUE BIOPHARMA trademark is filed in the Pharmaceutical Products category with the following description:

Biopharmaceutical preparations for treating cancer and autoimmune diseases; immunotherapeutic preparations for treating cancer and autoimmune diseases; none of the foregoing for medical diagnostic or analyte detection purposes
cue biopharma

General Information

Serial Number90252478
Word MarkCUE BIOPHARMA
Filing DateTuesday, October 13, 2020
Status700 - REGISTERED
Status DateTuesday, October 24, 2023
Registration Number7202411
Registration DateTuesday, October 24, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 25, 2022

Trademark Statements

Goods and ServicesBiopharmaceutical preparations for treating cancer and autoimmune diseases; immunotherapeutic preparations for treating cancer and autoimmune diseases; none of the foregoing for medical diagnostic or analyte detection purposes
Disclaimer with Predetermined Text"BIOPHARMA"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 1, 2020
Primary Code005
First Use Anywhere DateWednesday, July 12, 2023
First Use In Commerce DateWednesday, July 12, 2023

Trademark Owner History

Party NameCUE BIOPHARMA, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBoston, MA 02135
Party NameCUE BIOPHARMA, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02135
Party NameCUE BIOPHARMA, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Tuesday, October 24, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 24, 2023REGISTERED-PRINCIPAL REGISTER
Friday, September 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 22, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, September 21, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, September 21, 2023STATEMENT OF USE PROCESSING COMPLETE
Wednesday, September 13, 2023USE AMENDMENT FILED
Thursday, September 21, 2023SOU EXTENSION 2 GRANTED
Thursday, September 14, 2023SOU EXTENSION 2 FILED
Thursday, September 21, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 14, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, September 13, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, June 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 16, 2023SOU EXTENSION 1 GRANTED
Friday, June 16, 2023SOU EXTENSION 1 FILED
Friday, June 16, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, December 20, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 25, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 25, 2022PUBLISHED FOR OPPOSITION
Wednesday, October 5, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, September 19, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 18, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Saturday, September 18, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Saturday, September 18, 2021LETTER OF SUSPENSION E-MAILED
Saturday, September 18, 2021SUSPENSION LETTER WRITTEN
Friday, September 17, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 16, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 16, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 19, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 19, 2021NON-FINAL ACTION E-MAILED
Friday, March 19, 2021NON-FINAL ACTION WRITTEN
Thursday, March 11, 2021ASSIGNED TO EXAMINER
Tuesday, December 1, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 16, 2020NEW APPLICATION ENTERED

Related Keywords

biopharma diseases cancer autoimmune treating preparations analyte detection purposes diagnostic immunotherapeutic